This suggests that CORT treatment induces muscle GR–independent systemic insulin resistance initially but induces muscle GR–dependent insulin resistance via the induction of hyperinsulinemia during long-term CORT treatment. The gene discussed is NR3C1; the disease is Insulin resistance.